KURE Performance — KraneShares MSCI All China Health Care Index ETF
Data updated: 2026-08-28
KURE returned −8.80% year to date and −3.15% over one year to Jun 2026. Annualised returns are −2.78% over 3 years and −16.06% over 5 years. The fund beat its China Health Care Equity category average: $100 invested three years ago grew to $92, against $84 for the category, and to $97 over one year, against $97. Volatility over the past three years was 26.24% a year. In the 12 months to Jun 2026 the fund lost a net $15.5M, and assets reached $71.23M.
KURE Growth of $100
What $100 invested in KraneShares MSCI All China Health Care Index ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the China Health Care Equity category average over the same months.
| Period | KURE | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $97 | $97 |
| 3 years (Jul 2023 – Jun 2026) | $92 | $84 |
| 5 years (Jul 2021 – Jun 2026) | $42 | $46 |
| Since data start (Jul 2019 – Jun 2026) | $94 | $91 |
KURE Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −8.80% |
| 1 year | −3.15% |
| 3 years (annualised) | −2.78% |
| 5 years (annualised) | −16.06% |
KURE Annual Returns
Calendar-year total returns of KraneShares MSCI All China Health Care Index ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −8.80% |
| 2025 | +24.84% |
| 2024 | −17.38% |
| 2023 | −17.31% |
| 2022 | −25.39% |
| 2021 | −15.88% |
| 2020 | +67.28% |
| 2019 (Jul–Dec) | +14.73% |
KURE Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −4.4% | −0.8% | +4.0% | −3.0% | −6.6% | +2.0% | — | — | — | — | — | — |
| 2025 | +3.8% | +6.7% | −1.5% | +2.3% | +6.1% | −0.6% | +3.5% | +3.1% | +16.7% | −6.9% | −0.9% | −7.6% |
| 2024 | −7.5% | +11.1% | −18.8% | −5.9% | −4.3% | +1.1% | +23.2% | +0.5% | +2.9% | −5.2% | +0.5% | −10.4% |
| 2023 | −3.5% | −7.3% | +8.8% | −5.5% | −8.5% | +0.6% | +1.2% | −7.1% | +5.3% | −6.4% | +2.7% | +2.7% |
| 2022 | −3.7% | +1.9% | −15.3% | +12.8% | −0.8% | −12.6% | −13.6% | −4.5% | −7.1% | +4.3% | +15.1% | −0.2% |
| 2021 | −4.3% | −2.3% | +5.2% | +3.3% | +3.2% | +11.8% | +3.9% | −9.1% | −13.3% | −6.0% | −1.9% | −5.0% |
| 2020 | −3.8% | +3.7% | +2.4% | +18.0% | +2.4% | +10.4% | −6.0% | +0.3% | +12.0% | +16.0% | −2.9% | +3.3% |
| 2019 | — | — | — | — | — | — | −2.9% | +4.4% | +2.5% | +4.7% | −4.1% | +10.0% |
KURE Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 26.24%
- 3-year Sharpe ratio: -0.28 (vs 4.5% risk-free rate)
- Best month: +23.17% (Jul 2024)
- Worst month: −18.81% (Mar 2024)
KURE Fund Flows
Monthly money in and out of KraneShares MSCI All China Health Care Index ETF, from SEC Form N-PORT.
- 12-month net flow: −$15.5M
- 12-month gross sales (incl. reinvestments): $27.0M
- Sales ÷ redemptions: 0.64×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $4K | $3.3M | −$3.3M |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $4.6M | $0 | $4.6M |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $3K | $1.9M | −$1.9M |
| Nov 2025 | $284 | $7.7M | −$7.7M |
| Oct 2025 | −$6K | $5.6M | −$5.6M |
| Sep 2025 | $6.4M | $0 | $6.4M |
| Aug 2025 | $5.7M | $20.8M | −$15.1M |
| Jul 2025 | $10.3M | $3.1M | $7.2M |
KURE Assets Under Management
Net assets of KraneShares MSCI All China Health Care Index ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $71.23M |
| 2026-03-31 | $80.42M |
| 2025-12-31 | $77.20M |
| 2025-09-30 | $111.00M |
| 2025-06-30 | $89.93M |
| 2025-03-31 | $86.60M |
| 2024-12-31 | $37.18M |
| 2024-09-30 | $47.50M |
| 2024-06-30 | $39.93M |
| 2024-03-31 | $46.83M |
| 2023-12-31 | $60.56M |
| 2023-09-30 | $67.92M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.